Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
EW Edwards Lifesciences Corp
COP ConocoPhillips
FBP First Bancorp
PTCT PTC Therapeutics Inc
ROKU Roku Inc
WORK Slack Technologies Inc
ARKW ARK Next Generation Internet ETF
SPOT Spotify Technology SA
GBTC Grayscale Bitcoin Trust (BTC)
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Closing Price
$275.84
Day's Change
-4.45 (-1.59%)
Bid
--
Ask
--
B/A Size
--
Day's High
282.60
Day's Low
275.43
Volume
(Heavy Day)
Volume:
1,765,034

10-day average volume:
1,347,475
1,765,034

Display:

Providers:

UpdateCancel
6 providers
January 12, 2021
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BIIB, PINS and KNDI

NEW YORK, NY / ACCESSWIRE / January 12, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the...(Accesswire)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BIIB, YY and OTGLY

NEW YORK, NY / ACCESSWIRE / January 12, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you...(Accesswire)

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Biogen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ: BIIB) for violations of 10(b) and 20(a) of the Securities Exchange Act of...(PR Newswire)

January 11, 2021
BIIB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of January 12, 2021 in the Class Action Filed on Behalf of Biogen Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - January 11, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Biogen Inc. (NASDAQ: BIIB) alleging that the Company violated federal securities laws.(Newsfile)

BIIB FILING DEADLINE TOMORROW: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc.

Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the...(Globe Newswire)

CLASS ACTION UPDATE for BIIB, BABA and NAK: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / January 11, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff...(Accesswire)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 12, 2021 - BIIB

New York, New York--(Newsfile Corp. - January 11, 2021) - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Biogen Inc. (NASDAQ: BIIB) ("Biogen")...(Newsfile)

Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors

Click here to join the case The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Biogen, Inc. ("Biogen" or "the Company") (NASDAQ: BIIB) investors that acquired securities between October 22, 2019 to...(Globe Newswire)

Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone

-- Cognitive health -- the ability to think clearly, to learn and to remember -- is an indicator of brain health and important to performing daily activities Biogen Inc. (Nasdaq: BIIB) today announced a new virtual research study, in collaboration...(Globe Newswire)

Biogen to Launch Pioneering Study to Develop Digital Biomarkers of Cognitive Health Using Apple Watch and iPhone

- The study aims to identify digital biomarkers to help monitor cognitive performance and health including potentially detecting mild cognitive impairment, an early indicator of certain forms of dementia such as Alzheimer's disease (Thomson Reuters ONE)

January 10, 2021
LAWSUITS FILED AGAINST BIIB, SPLK and QSR - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / January 10, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods...(Accesswire)

January 09, 2021
DEADLINE FOR BIIB INVESTORS: Bernstein Liebhard LLP Reminds Investors That Only 3 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc.

New York, New York--(Newsfile Corp. - January 9, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed...(Newsfile)

January 08, 2021
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Biogen, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors...(Globe Newswire)

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BIIB, NAK and NERV

NEW YORK, NY / ACCESSWIRE / January 8, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the...(Accesswire)

CLASS ACTION UPDATE for BIIB, BABA and QS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff...(Accesswire)

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)

Law Offices of Howard G. Smith reminds investors of the upcoming January 12, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Biogen, Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) securities...(PR Newswire)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Biogen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 12, 2021 - BIIB

New York, New York--(Newsfile Corp. - January 8, 2021) - The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Biogen Inc. (NASDAQ: BIIB) ("Biogen")...(Newsfile)

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen, Inc. (BIIB)

The Law Offices of Frank R. Cruz reminds investors of the upcoming January 12, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Biogen, Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) securities...(BusinessWire)

Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA(R) (nusinersen) in Patients Treated With Zolgensma(R) (onasemnogene abeparvovec)

- The global Phase 4 RESPOND study will evaluate the efficacy and safety of SPINRAZA in patients with a suboptimal clinical response to Zolgensma - Clinical and real-world experience have reported that some patients previously treated with Zolgensma...(Thomson Reuters ONE)

Biogen Announces First Patient Treated in RESPOND Study Evaluating Benefit of SPINRAZA(R) (nusinersen) in Patients Treated With Zolgensma(R) (onasemnogene abeparvovec)

Biogen Inc. (Nasdaq: BIIB) today announced that the first patient has been treated in the global clinical study, RESPOND. The Phase 4 study will examine the clinical benefit and assess the safety of SPINRAZA (nusinersen) in infants and children...(Globe Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.